+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Global Forecast 2025-2030- Product Image
Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Global Forecast 2025-2030- Product Image
Sale

Circulating Tumor Cell Market by Specimen, Technology, Product, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5311178
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Circulating Tumor Cell Market grew from USD 12.44 billion in 2023 to USD 14.17 billion in 2024. It is expected to continue growing at a CAGR of 13.99%, reaching USD 31.12 billion by 2030.

Circulating Tumor Cells (CTCs) are cancer cells that have detached from a primary tumor and circulate in the bloodstream, serving as crucial biomarkers for cancer diagnostics, prognosis, and treatment monitoring. The growing necessity for non-invasive, real-time cancer diagnostics is driving the CTC market. From liquid biopsies, which offer a less invasive alternative to traditional tissue biopsies, to monitoring disease progression and treatment efficacy, the applications of CTCs are expansive. They are fundamentally utilized in oncology research, enabling personalized cancer therapy by analyzing the genetic profile of cancer cells. The end-use scope includes research institutes, hospitals, and pharmaceutical companies, primarily for the development of targeted therapies. The market's growth is primarily influenced by technological advancements in cancer detection and ongoing R&D investments. The demand for precision medicine and the rising prevalence of cancer globally further propel this sector. Emerging opportunities lie in the integration of artificial intelligence with CTC detection and analysis to improve accuracy and predictive capabilities. However, the market faces challenges such as high costs of CTC detection methods, lack of standardization, and the technical complexity of isolating these rare cells. Addressing these issues through research in automation and cost-efficiency improvements could significantly broaden market adoption. Innovation prospects include developing advanced microfluidic devices and enhancing computational analysis techniques for better CTC detection and characterization. The nature of the CTC market is highly dynamic, with a competitive landscape driven by technological evolution and collaborations between biotech firms and research institutions. Companies should focus on partnerships and R&D to develop cost-effective and robust CTC detection methods. Emphasizing regulatory compliance and securing funding for exploratory studies could further aid in overcoming current limitations and capturing potential market share.

Understanding Market Dynamics in the Circulating Tumor Cell Market

The Circulating Tumor Cell Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increased spending in cancer-related therapies
    • Prevalence of cancer across the globe
    • Rising awareness and focus on early cancer detection
  • Market Restraints
    • Lack of awareness about CTC systems
  • Market Opportunities
    • Technological advancements in bioengineering and biomedical practices
    • Demand for minimally invasive diagnostics in recent years
  • Market Challenges
    • Stringent government regulations for the approval of CTC technologies

Exploring Porter’s Five Forces for the Circulating Tumor Cell Market

Porter’s Five Forces framework further strengthens the insights of the Circulating Tumor Cell Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Circulating Tumor Cell Market

External macro-environmental factors deeply influence the performance of the Circulating Tumor Cell Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Circulating Tumor Cell Market

The Circulating Tumor Cell Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Circulating Tumor Cell Market

The Circulating Tumor Cell Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Circulating Tumor Cell Market

The Circulating Tumor Cell Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Circulating Tumor Cell Market, highlighting leading vendors and their innovative profiles. These include BioFluidica, Biolidics Limited, Creatv MicroTech, Inc., Epic Sciences, Fluxion Biosciences, Inc., Greiner Bio One International GmbH, Ikonisys Inc., IVDiagnostics, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec GmbH, NanoString Technologies, Inc., Precision Medicine Group, LLC, QIAGEN GmbH, Rarecells Diagnostics, ScreenCell, STEMCELL Technologies, Inc., Sysmex Corporation, and Vitatex, Inc.

Market Segmentation & Coverage

This research report categorizes the Circulating Tumor Cell Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Specimen
    • Blood
    • Bone Marrow
  • Technology
    • CTC Analysis
    • CTC Detection & Enrichment Methods
      • Combined Methods
      • Density-Based Separation
      • Immunocapture
        • Negative Selection
        • Positive Selection
      • Size-Based Separation
        • Membrane-Based
        • Microfluidic-Based
    • CTC Direct Detection Methods
      • Microscopy
      • SERS
  • Product
    • Blood Collection Tubes
    • Devices or Systems
    • Kits & Reagents
  • Application
    • Clinical/ Liquid Biopsy
      • Risk Assessment
      • Screening & Monitoring
    • Research
      • Cancer Stem Cell & Tumorigenesis Research
      • Drug or Therapy Development
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased spending in cancer-related therapies
5.1.1.2. Prevalence of cancer across the globe
5.1.1.3. Rising awareness and focus on early cancer detection
5.1.2. Restraints
5.1.2.1. Lack of awareness about CTC systems
5.1.3. Opportunities
5.1.3.1. Technological advancements in bioengineering and biomedical practices
5.1.3.2. Demand for minimally invasive diagnostics in recent years
5.1.4. Challenges
5.1.4.1. Stringent government regulations for the approval of CTC technologies
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Circulating Tumor Cell Market, by Specimen
6.1. Introduction
6.2. Blood
6.3. Bone Marrow
7. Circulating Tumor Cell Market, by Technology
7.1. Introduction
7.2. CTC Analysis
7.3. CTC Detection & Enrichment Methods
7.3.1. Combined Methods
7.3.2. Density-Based Separation
7.3.3. Immunocapture
7.3.3.1. Negative Selection
7.3.3.2. Positive Selection
7.3.4. Size-Based Separation
7.3.4.1. Membrane-Based
7.3.4.2. Microfluidic-Based
7.4. CTC Direct Detection Methods
7.4.1. Microscopy
7.4.2. SERS
8. Circulating Tumor Cell Market, by Product
8.1. Introduction
8.2. Blood Collection Tubes
8.3. Devices or Systems
8.4. Kits & Reagents
9. Circulating Tumor Cell Market, by Application
9.1. Introduction
9.2. Clinical/ Liquid Biopsy
9.2.1. Risk Assessment
9.2.2. Screening & Monitoring
9.3. Research
9.3.1. Cancer Stem Cell & Tumorigenesis Research
9.3.2. Drug or Therapy Development
10. Americas Circulating Tumor Cell Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Circulating Tumor Cell Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Circulating Tumor Cell Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. CIRCULATING TUMOR CELL MARKET RESEARCH PROCESS
FIGURE 2. CIRCULATING TUMOR CELL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. CIRCULATING TUMOR CELL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. CIRCULATING TUMOR CELL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CIRCULATING TUMOR CELL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CIRCULATING TUMOR CELL MARKET DYNAMICS
TABLE 7. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BONE MARROW, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY COMBINED METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DENSITY-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MEMBRANE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROFLUIDIC-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DEVICES OR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RISK ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY SCREENING & MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY CANCER STEM CELL & TUMORIGENESIS RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY DRUG OR THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 72. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 73. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 76. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 77. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 78. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 81. CANADA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 91. MEXICO CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES CIRCULATING TUMOR CELL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 112. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 118. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 119. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 120. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 123. AUSTRALIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 124. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 125. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 127. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 128. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 129. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 130. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 133. CHINA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 134. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 135. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 137. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 138. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 139. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 140. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 143. INDIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 145. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 147. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 148. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 149. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 150. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 153. INDONESIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 154. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 155. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 157. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 158. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 159. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 160. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 163. JAPAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 164. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 165. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 167. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 168. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 169. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 170. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 173. MALAYSIA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 174. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 175. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 177. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 178. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 179. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 180. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 183. PHILIPPINES CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 184. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 185. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 187. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 188. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 189. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 190. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 193. SINGAPORE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 204. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 205. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 207. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 208. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 209. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 210. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 213. TAIWAN CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 214. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 215. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 217. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 218. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 219. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 220. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 223. THAILAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 233. VIETNAM CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CIRCULATING TUMOR CELL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 245. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 246. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 248. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 249. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 251. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 254. DENMARK CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 255. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 256. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 258. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 259. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 260. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 263. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 264. EGYPT CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 265. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 266. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 268. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 269. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 270. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 271. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 274. FINLAND CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 275. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 276. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 278. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 279. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 280. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 281. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 284. FRANCE CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 285. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 286. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 288. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 289. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 290. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 291. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 294. GERMANY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 300. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 301. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 302. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 304. ISRAEL CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 305. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 306. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 308. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 309. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 310. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 311. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 312. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030 (USD MILLION)
TABLE 314. ITALY CIRCULATING TUMOR CELL MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 315. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SPECIMEN, 2018-2030 (USD MILLION)
TABLE 316. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DETECTION & ENRICHMENT METHODS, 2018-2030 (USD MILLION)
TABLE 318. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY IMMUNOCAPTURE, 2018-2030 (USD MILLION)
TABLE 319. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY SIZE-BASED SEPARATION, 2018-2030 (USD MILLION)
TABLE 320. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CTC DIRECT DETECTION METHODS, 2018-2030 (USD MILLION)
TABLE 321. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 322. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. NETHERLANDS CIRCULATING TUMOR CELL MARKET SIZE, BY CLINICAL/ LIQUID BIOPSY, 2018-2030

Companies Mentioned

The leading players in the Circulating Tumor Cell Market, which are profiled in this report, include:
  • BioFluidica
  • Biolidics Limited
  • Creatv MicroTech, Inc.
  • Epic Sciences
  • Fluxion Biosciences, Inc.
  • Greiner Bio One International GmbH
  • Ikonisys Inc.
  • IVDiagnostics
  • LungLife AI, Inc.
  • Menarini Silicon Biosystems
  • Miltenyi Biotec GmbH
  • NanoString Technologies, Inc.
  • Precision Medicine Group, LLC
  • QIAGEN GmbH
  • Rarecells Diagnostics
  • ScreenCell
  • STEMCELL Technologies, Inc.
  • Sysmex Corporation
  • Vitatex, Inc

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 14.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 31.12 Billion
Compound Annual Growth Rate13.9%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone Marrow, Blood), Product, Technology, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Circulating Tumor Cells Market Size, Share & Trends Analysis Report by Application (Clinical/Liquid Biopsy, Research), Specimen (Bone Marrow, Blood), Product, Technology, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032 - Product Image

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Circulating Tumor Cells Global Market Report 2024 - Product Image

Circulating Tumor Cells Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032 - Product Image

Circulating Tumor Cells Patent Landscape Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report - Product Image

Circulating Tumor Cell (CTC) Diagnostics - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Circulating Tumor Cell Market

Circulating Tumor Cells (CTCs) are a type of biomarker used to detect and monitor cancer. CTCs are cells that have been shed from a tumor and are present in the bloodstream. They can be used to diagnose cancer, monitor its progression, and assess the effectiveness of treatments. CTCs are also used to identify new therapeutic targets and to develop personalized treatments. CTCs are a rapidly growing market, with a range of products and services available to researchers and clinicians. Companies in the CTC market offer technologies for isolating, analyzing, and characterizing CTCs, as well as services for CTC-based diagnostics and drug development. Examples of companies in the CTC market include ApoCell, Menarini Silicon Biosystems, and RareCyte. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.